Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery

Pediatrics

Volumn 118, Issue 1, 2006, Pages

  Schroth, Michael ^a,b   Plank, Christian ^a   Meißner, Udo ^a   Eberle, Klaus Peter ^a   Weyand, Michael ^a   Cesnjevar, Robert ^a   Dötsch, Jörg ^a   Rascher, Wolfgang ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Capillary leakage; Cardiopulmonary bypass; Hypertonic hyperoncotic solutions; Low output failure; Pediatrics

Indexed keywords

DOBUTAMINE; HETASTARCH; SODIUM CHLORIDE; PLASMA SUBSTITUTE;

ARTICLE; BLEEDING; BLOOD SAMPLING; CAPILLARY LEAK SYNDROME; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; FLUID BALANCE; HEART ATRIUM SEPTUM DEFECT; HEART FUNCTION; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LUNG FLUID; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; OSMOLALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; THERMODILUTION; CHILD; HEART; HEART SURGERY; HEMODILUTION; HEMODYNAMICS; MICROCIRCULATION; OSMOLARITY; POSTOPERATIVE PERIOD; VASCULAR RESISTANCE;

CAPILLARY LEAK SYNDROME; CARDIAC OUTPUT; CARDIAC SURGICAL PROCEDURES; CHILD; FEMALE; HEART; HEMODILUTION; HEMODYNAMIC PROCESSES; HUMANS; MALE; MICROCIRCULATION; OSMOLAR CONCENTRATION; PLASMA SUBSTITUTES; POSTOPERATIVE PERIOD; RESEARCH SUPPORT, NON-U.S. GOV'T; SALINE SOLUTION, HYPERTONIC; THERMODILUTION; VASCULAR RESISTANCE;

EID: 33845998587     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2795     Document Type: Article

References (42)

1. Albrecht MD, Schroth M, Fahnle M, Ellinger K. Effects of hypertonic-hyperoncotic infusion on the human atrial natriuretic factor in a standardized clinical trial. Shock. 1995;3: 152-156
2. de Felippe J Jr, Timoner J, Velasco IT, Lopes OU, Rocha-e-Silva M Jr. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections. Lancet. 1980;2:1002-1004
3. Kreimeier U, Messmer K. Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand. 2002;46:625-638
4. Rocha-e-Silva M, Negraes GA, Soares AM, Pontieri V, Loppnow L. Hypertonic resuscitation from severe hemorrhagic shock: patterns of regional circulation. Circ Shock. 1986;19: 165-175
5. Ellinger K, Fahnle M, Schroth M, Albrecht DM. Optimal preoperative titrated dosage of hypertonic-hyperoncotic solutions in cardiac risk patients. Shock. 1995;3:167-172
6. Kreimeier U, Brueckner UB, Schmidt J, Messmer K. Instantaneous restoration of regional organ blood flow after severe hemorrhage: effect of small-volume resuscitation with hypertonic-hyperoncotic solutions. J Surg Res. 1990;49:493-503
7. Corso CO, Okamoto S, Ruttinger D, Messmer K. Hypertonic saline dextran attenuates leukocyte accumulation in the liver after hemorrhagic shock and resuscitation. J Trauma. 1999;46: 417-423
8. Vollmar B, Lang G, Menger MD, Messmer K. Hypertonic hydroxyethyl starch restores hepatic microvascular perfusion in hemorrhagic shock. Am J Physiol. 1994;266(pt 2):H1927-H1934
9. Nolte D, Lehr HA, Messmer K. Adenosine inhibits postischemic leukocyte-endothelium interaction in postcapillary venules of the hamster. Am J Physiol. 1991;261(pt 2):H651-H655
10. Nolte D, Lorenzen A, Lehr HA, Zimmer FJ, Klotz KN, Messmer K. Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol. 1992;346:234-237
11. Pickelmann S, Nolte D, Leiderer R, Schutze E, Messmer K. Attenuation of postischemic reperfusion injury in striated skin muscle by diaspirin-cross- linked Hb. Am J Physiol. 1998;275(pt 2):H361-H368
12. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999;90: 1265-1270
13. Vassar MJ, Perry CA, Holcroft JW. Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Arch Surg. 1990;125:1309-1315
14. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg. 1991;213:482-491
15. Kien ND, Kramer GC, White DA. Acute hypotension caused by rapid hypertonic saline infusion in anesthetized dogs. Anesth Analg. 1991;73:597-602
16. Kreimeier U, Christ F, Kraft D, et al. Anaphylaxis due to hydroxyethyl-starch-reactive antibodies. Lancet. 1995;346: 49-50
17. Carli P, Orliaguet G. Severe traumatic brain injury in children. Lancet. 2004;363:584-585
18. Khanna S, Davis D, Peterson B, et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med. 1000;28:1144-1151
19. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med. 1998;26:1265-1270
20. White PA, Chaturvedi RR, Shore D, et al. Left ventricular parallel conductance during cardiac cycle in children with congenital heart disease. Am J Physiol. 1997;273(pt 2):H295-H302
21. Rocha ESR, Caneo LF, Lourenco Filho DD, et al. First use of hypertonic saline dextran in children: a study in safety and effectiveness for atrial septal defect surgery. Shock. 2003;20: 427-430
22. Cecchetti C, Stoppa F, Vanacore N, et al. Monitoring of intrathoracic volemia and cardiac output in critically ill children. Minerva Anestesiol. 2003;69:907-918
23. Michard F, Alaya S, Zarka V, Bahloul M, Richard C, Teboul JL. Global end-diastolic volume as an indicator of cardiac preload in patients with septic shock. Chest. 2003;124:1900-1908
24. Boldt J, Menges T, Wollbruck M, Hammermann H, Hempelmann G. Is continuous cardiac output measurement using thermodilution reliable in the critically ill patient? Crit Care Med. 1994;22:1913-1918
25. Schranz D, Bauer J, Wiemann J, et al. Treatment of acute low cardiac output syndrome after surgery of congenital heart defects: value of enoximone [in German]. Z Kardiol. 1994; 83(suppl);2:83-89
26. Tollofsrud S, Noddeland H. Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions. Acta Anaesthesiol Scand. 1998;42: 154-161
27. Christ F, Niklas M, Kreimeier U, Lauterjung L, Peter K, Messmer K. Hyperosmotic-hyperoncotic solutions during abdominal aortic aneurysm (AAA) resection. Acta Anaesthesiol Scand. 1997;41(pt 1):62-70
28. Berg RA, Padbury JF, Donnerstein RL, Klewer SE, Hutter JJ Jr. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents. J Pharmacol Exp Ther. 1993;265: 1232-1238
29. Lang RM, Borow KM, Neumann A, Janzen D. Systemic vascular resistance: an unreliable index of left ventricular afterload. Circulation. 1986;74:1114-1123
30. Levy RJ, Chiavacci RM, Nicolson SC, et al. An evaluation of a noninvasive cardiac output measurement using partial carbon dioxide rebreathing in children. Anesth Analg. 2004;99: 1642-1647
31. de Kleijn ED, Hazelzet JA, Kornelisse RF, de Groot R. Pathophysiology of meningococcal sepsis in children. Eur J Pediatr. 1998;157:869-880
32. Hazelzet JA, de Groot R, van Mierlo G, et al. Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun. 1998;66:5350-5356
33. Khabar KS, elBarbary MA, Khouqeer F, Devol E, al-Gain S, al-Halees A. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85: 97-103
34. Nurnberger W, Heying R, Burdach S, Gobel U. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol. 1997;75:95-101
35. Takeda A, Okumura S, Miyamoto T, Hagio M, Fujinaga T. Comparison of extravascular lung water volume with radiographic findings in dogs with experimentally increased permeability pulmonary edema. J Vet Med Sci. 1995;57:481-485
36. Hartl R, Medary MB, Ruge M, Arfors KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma. 1997;42(suppl):S41-S47
37. Moritz ML, Ayus JC. The changing pattern of hypernatremia in hospitalized children. Pediatrics. 1999;104(pt 1):435-439
38. Moder KG, Hurley DL. Fatal hypernatremia from exogenous salt intake: report of a case and review of the literature. Mayo Clin Proc. 1990;65:1587-1594
39. Prien T, Thulig B, Wusten R, Schoofs J, Weyand M, Lawin P. Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses [in German]. Zentralbl Chir. 1993;118: 257-263; discussion 264-266
40. Boldt J, Knothe C, Schindler E, Hammermann H, Dapper F, Hempelmann G. Volume replacement with hydroxyethyl starch solution in children. Br J Anaesth. 1993;70:661-665
41. Schimetta W, Schochl H, Kroll W, Polz W, Polz G, Mauritz W. Safety of hypertonic hyperoncotic solutions: A survey from Austria. Wien Klin Wochenschr. 2002;114:89-95
42. Kapiotis S, Quehenberger P, Eichler HG, et al. Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med. 1994;22:606-612